(VIANEWS) – Shares of Xenetic Biosciences (NASDAQ: XBIO) slid by a staggering 26.26% in 30 days from $0.99 to $0.73 at 23:51 EST on Monday, after five consecutive sessions in a row of losses. NASDAQ is falling 0.3% to $11,354.62, after three consecutive sessions in a row of losses.

Xenetic Biosciences’s last close was $0.73, 87.15% under its 52-week high of $5.68.


Today’s last reported volume for Xenetic Biosciences is 72192 which is 65.92% below its average volume of 211876.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the present quarter and a decline by 33.8% for the next. The company’s growth estimates for the present quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.


Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.05%, a negative 1.55%, and a positive 3.89%, respectively.

Xenetic Biosciences’s highest amplitude of average volatility was 2.05% (last week), 4.91% (last month), and 3.89% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be overbought (>=80).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.73 at 23:51 EST, way below its 52-week low of $1.21.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way below its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.

More news about Xenetic Biosciences (XBIO).


Please enter your comment!
Please enter your name here